Biomimetic supramolecular designs for the controlled release of growth factors in bone regeneration

Adv Drug Deliv Rev. 2015 Nov 1:94:63-76. doi: 10.1016/j.addr.2015.08.003. Epub 2015 Aug 29.

Abstract

The extracellular matrix (ECM) of tissues is an assembly of insoluble macromolecules that specifically interact with soluble bioactive molecules and regulate their distribution and availability to cells. Recapitulating this ability has been an important target in controlled growth factor delivery strategies for tissue regeneration and requires the design of multifunctional carriers. This review describes the integration of supramolecular interactions on the design of delivery strategies that encompass self-assembling and engineered affinity components to construct advanced biomimetic carriers for growth factor delivery. Several glycan- and peptide-based self-assemblies reported in the literature are highlighted and commented upon. These examples demonstrate how molecular design and chemistry are successfully employed to create versatile multifunctional molecules which self-assemble/disassemble in a precisely predicted manner, thus controlling compartmentalization, transport and delivery. Finally, we discuss whether recent advances in the design and preparation of supramolecular delivery systems have been sufficient to drive real translation towards a clinical impact.

Keywords: Biomimetic; Extracellular matrix; Glycosaminoglycans; Growth factors; Molecular recognition; Multivalent interactions; Peptides; Self-assembly.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomimetic Materials / chemistry
  • Biomimetic Materials / pharmacology
  • Bone Regeneration / drug effects*
  • Bone Regeneration / physiology*
  • Delayed-Action Preparations
  • Drug Carriers
  • Drug Delivery Systems / methods*
  • Drug Design*
  • Drug Liberation
  • Extracellular Matrix / metabolism*
  • Glycosaminoglycans / chemistry
  • Humans
  • Intercellular Signaling Peptides and Proteins / administration & dosage
  • Intercellular Signaling Peptides and Proteins / pharmacology*
  • Structure-Activity Relationship

Substances

  • Delayed-Action Preparations
  • Drug Carriers
  • Glycosaminoglycans
  • Intercellular Signaling Peptides and Proteins